Clinical Trial Update: Study of Verinurad in Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial of verinurad in heart failure with preserved ejection fraction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Verinurad (verinurad)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF) | Phase 2 | Status: COMPLETED | Results posted: 2023-06-29